Among all dysregulated lncRNAs in cancers, PVT1 is particularly compelling because emerging studies have revealed that PVT1 fulfills significant oncogenic effects in the onset and progression of various cancers, including ccRCC [19–28]. The gene discussed is PVT1; the disease is nonpapillary renal cell carcinoma.